These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36379378)
1. The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N Bluemling GR; Mao S; Natchus MG; Painter W; Mulangu S; Lockwood M; De La Rosa A; Brasel T; Comer JE; Freiberg AN; Kolykhalov AA; Painter GR Antiviral Res; 2023 Jan; 209():105453. PubMed ID: 36379378 [TBL] [Abstract][Full Text] [Related]
2. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection. Painter GR; Bowen RA; Bluemling GR; DeBergh J; Edpuganti V; Gruddanti PR; Guthrie DB; Hager M; Kuiper DL; Lockwood MA; Mitchell DG; Natchus MG; Sticher ZM; Kolykhalov AA Antiviral Res; 2019 Nov; 171():104597. PubMed ID: 31494195 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Warren TK; Jordan R; Lo MK; Ray AS; Mackman RL; Soloveva V; Siegel D; Perron M; Bannister R; Hui HC; Larson N; Strickley R; Wells J; Stuthman KS; Van Tongeren SA; Garza NL; Donnelly G; Shurtleff AC; Retterer CJ; Gharaibeh D; Zamani R; Kenny T; Eaton BP; Grimes E; Welch LS; Gomba L; Wilhelmsen CL; Nichols DK; Nuss JE; Nagle ER; Kugelman JR; Palacios G; Doerffler E; Neville S; Carra E; Clarke MO; Zhang L; Lew W; Ross B; Wang Q; Chun K; Wolfe L; Babusis D; Park Y; Stray KM; Trancheva I; Feng JY; Barauskas O; Xu Y; Wong P; Braun MR; Flint M; McMullan LK; Chen SS; Fearns R; Swaminathan S; Mayers DL; Spiropoulou CF; Lee WA; Nichol ST; Cihlar T; Bavari S Nature; 2016 Mar; 531(7594):381-5. PubMed ID: 26934220 [TBL] [Abstract][Full Text] [Related]
4. A review on the antagonist Ebola: A prophylactic approach. Khan FN; Qazi S; Tanveer K; Raza K Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326 [TBL] [Abstract][Full Text] [Related]
5. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin. Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342 [TBL] [Abstract][Full Text] [Related]
20. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection. Wu W; Liu S Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]